Xellia Pharmaceuticals is the global leader in fermentation-based non-beta-lactam anti-infectives. We manufacture and supply APIs as well as Finished Dosage Forms (FDFs) to over 500 pharmaceutical companies across 80 countries.
Headquartered in Copenhagen, Denmark, Xellia Pharmaceuticals boasts a global footprint, with manufacturing sites in Denmark, Hungary, and China, alongside R&D and commercial operations in an additional eight locations around the world. We stand as the sole European manufacturer of several of our products and possess a rich legacy of over 120 years in the pharmaceutical industry.
Company Details
- Employees
- 933
- Founded
- -
- Address
- Dalslandsgade 11, Copenhagen,2300,denmark
- Phone
- (453) 264-5500
- in****@****lia.com
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- xellia.com
- Keywords
- Active Pharmaceutical Ingredients, Contract Manufacturing, Finished Dosage Forms, Injectables, Anti-infectives, Critical care.
- HQ
- Copenhagen
Xellia Pharmaceuticals Questions
Xellia Pharmaceuticals's helpline number is (453) 264-5500
Xellia Pharmaceuticals's website is xellia.com
Xellia Pharmaceuticals's LinkedIn profile is https://www.linkedin.com/company/xellia-pharmaceuticals
Xellia Pharmaceuticals has
933 employees.
View email and phone details for 933
employees at Xellia Pharmaceuticals.
Xellia Pharmaceuticals's industry is
Pharmaceutical Manufacturing
Xellia Pharmaceuticals's top competitors are
Sagent Pharmaceuticals,
Leo Pharma,
Novo Nordisk,
Hikma Pharmaceuticals,
Lundbeck,
Bavarian Nordic,
Aj Vaccines,
Meitheal Pharmaceuticals, Inc.,
Fujifilm Biotechnologies,
Agc Biologics.
Xellia Pharmaceuticals's support email address is info.dk@xellia.com
Xellia Pharmaceuticals's categories are Pharmaceutical Manufacturing
Xellia Pharmaceuticals's founding year is 1903
